Diabetic Retina Exam Rate Does Not Increase With Phone Reminders in Non-HMO Population
NCT ID: NCT00799695
Last Updated: 2008-12-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
561 participants
INTERVENTIONAL
2008-01-31
2008-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Only half of patients with diabetes are screened regularly for diabetic retinopathy, and this proportion has been difficult to increase despite various interventions. Previous research focused on HMO patient groups because preventative care was thought to decrease plan costs. In addition, it was administratively feasible to track patient-doctor interactions.
This project builds on published research and institutional experience to determine an effective method for increasing the screening rate, in a mobile, non-HMO population. It uses administrative methods and information technology infrastructures, such as large scale electronic medical records and patient demographic databases, to identify existing patients requiring examinations.
Patients were telephoned by a trained service representative who offered and scheduled firm examination appointment times.
Hypothesis: Annual screening rates for diabetic retinopathy can be substantially improved in non-HMO patient groups by directly contacting patients and scheduling firm appointment times.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
HEALTH_SERVICES_RESEARCH
SINGLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
phone call contact
A sample of subjects who had not completed their annual diabetic screening exams were contacted by phone and offered appointments for eye exams
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* diabetic
* using the BCBSM payer plan
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Blue Cross Blue Shield of Michigan Foundation
OTHER
Henry Ford Health System
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Henry Ford Health System
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Robert M Levine,, MD
Role: PRINCIPAL_INVESTIGATOR
Henry Ford Health System
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Henry Ford Health System
Detroit, Michigan, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
F10030
Identifier Type: -
Identifier Source: secondary_id
13.13PIRAP
Identifier Type: -
Identifier Source: secondary_id
F10030
Identifier Type: -
Identifier Source: org_study_id